We are developing a liquid biopsy blood test for early detection and monitoring of a broad spectrum of human diseases. We use molecular biology, next generation sequencing, and advanced computational analysis to extract rich epigenetic information encoded in chromatin fragments circulating in the blood and transform it into concrete clinical information.